(Q39184893)

English

Biosimilars: a regulatory perspective from America

scientific article published on 12 May 2011

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

9 September 2017

Biosimilars: a regulatory perspective from America (English)

1 reference

stated in

Europe PubMed Central

9 September 2017

Jonathan Kay

1

0 references

publication date

12 May 2011

1 reference

stated in

Europe PubMed Central

9 September 2017

Arthritis Research and Therapy

1 reference

stated in

Europe PubMed Central

9 September 2017

13

1 reference

stated in

Europe PubMed Central

9 September 2017

3

1 reference

stated in

Europe PubMed Central

9 September 2017

112

1 reference

stated in

Europe PubMed Central

9 September 2017

Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218870

retrieved

15 June 2018

Eprex-associated pure red cell aplasia and leachates

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218870

retrieved

21 August 2018

Pure red-cell aplasia and epoetin therapy.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3218870

retrieved

21 August 2018

The FDA's assessment of follow-on protein products: a historical perspective

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21586106

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21586106

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1186/AR3310

1 reference

stated in

Europe PubMed Central

9 September 2017

release_62zr5mesiff37fpsvnmdyhn2km

0 references

PMC publication ID

3218870

1 reference

stated in

Europe PubMed Central

PMC publication ID

3218870

retrieved

9 September 2017

PubMed publication ID

21586106

1 reference

stated in

Europe PubMed Central

PMC publication ID

3218870

retrieved

9 September 2017

ResearchGate publication ID

51140352

0 references

(Q39184893)

Biosimilars: a regulatory perspective from America

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)